OVID icon

Ovid Therapeutics
OVID

Overview Fund Trends Analyst Outlook Journalist POV

45 hedge funds and large institutions have $81.8M invested in Ovid Therapeutics in 2017 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$18.3M
2
+$11.8M
3
+$6.74M
4
TCM
Tekla Capital Management
Massachusetts
+$5.23M
5
O
OppenheimerFunds
New York
+$4.46M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$18.3M
2
$11.8M
3
$6.74M
4
$5.23M
5
$4.46M
6
$4.24M
7
$3.76M
8
$3.64M
9
$3.5M
10
$3.04M
11
$2.35M
12
$2.33M
13
$2.29M
14
$2.16M
15
$1.37M
16
$1.04M
17
$923K
18
$604K
19
$520K
20
$367K
21
$328K
22
$320K
23
$301K
24
$292K
25
$233K
1
2